| Schedule of Segment Reporting Information |
Segment results for the three-month period ended March 28, 2025 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 1,474.2 | | | $ | 671.4 | | | $ | 500.6 | | | $ | 302.2 | | | $ | — | | Cost of sales | (593.3) | | | (223.2) | | | (246.0) | | | (124.1) | | | — | | Gross profit | 880.9 | | | 448.2 | | | 254.6 | | | 178.1 | | | — | | Operating expenses | (647.3) | | | (274.5) | | | (167.3) | | | (151.8) | | | (53.7) | | | | | | | | | | | | Operating profit (loss) | 233.6 | | | 173.7 | | | 87.3 | | | 26.3 | | | (53.7) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (32.0) | | | — | | | — | | | — | | | (32.0) | | | | | | | | | | | | Other non-operating expense, net | (0.2) | | | — | | | — | | | — | | | (0.2) | | Earnings before income taxes | $ | 201.4 | | | $ | 173.7 | | | $ | 87.3 | | | $ | 26.3 | | | $ | (85.9) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (134.9) | | | $ | (57.9) | | | $ | (27.2) | | | $ | (49.5) | | | $ | (0.3) | | | | | | | | | | | | Capital expenditure | $ | (26.7) | | | $ | (16.9) | | | $ | (5.6) | | | $ | (4.0) | | | $ | (0.2) | | | | | | | | | | | | |
Segment results for the three-month period ended March 29, 2024 are shown below ($ in millions): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Total | | Intelligent Operating Solutions | | Precision Technologies | | Advanced Healthcare Solutions | | Unallocated Corporate Costs and Other | Sales | $ | 1,524.5 | | | $ | 665.7 | | | $ | 559.0 | | | $ | 299.8 | | | $ | — | | Cost of sales | (620.3) | | | (222.4) | | | (272.7) | | | (125.2) | | | — | | Gross profit | 904.2 | | | 443.3 | | | 286.3 | | | 174.6 | | | — | | Operating expenses | (665.1) | | | (279.2) | | | (200.3) | | | (147.1) | | | (38.5) | | Gain on sale of property (a) | 63.1 | | | — | | | 63.1 | | | — | | | — | | Operating profit (loss) | 302.2 | | | 164.1 | | | 149.1 | | | 27.5 | | | (38.5) | | Non-operating income (expense), net | | | | | | | | | | Interest expense, net | (44.0) | | | — | | | — | | | — | | | (44.0) | | | | | | | | | | | | Other non-operating expense, net | (24.2) | | | — | | | — | | | — | | | (24.2) | | Earnings before income taxes | $ | 234.0 | | | $ | 164.1 | | | $ | 149.1 | | | $ | 27.5 | | | $ | (106.7) | | | | | | | | | | | | Depreciation and amortization expenses | $ | (136.8) | | | $ | (57.3) | | | $ | (29.4) | | | $ | (50.1) | | | $ | — | | | | | | | | | | | | Capital expenditure | $ | (26.4) | | | $ | (18.7) | | | $ | (4.1) | | | $ | (2.7) | | | $ | (0.9) | | | | | | | | | | | | (a) Refer to Note 1 for further detail on Gain on sale of property. |
Segment Assets: | | | | | | | | | | | | | | | As of | | ($ in millions) | March 28, 2025 | | December 31, 2024 | | | | Intelligent Operating Solutions | $ | 6,333.5 | | | $ | 6,320.1 | | | | | Precision Technologies | 4,770.6 | | | 4,691.9 | | | | | Advanced Healthcare Solutions | 4,964.3 | | | 5,008.6 | | | | | Total segment assets | 16,068.4 | | | 16,020.6 | | | | Other (a) | 1,068.6 | | | 995.5 | | | | | | | | | | | Total assets | $ | 17,137.0 | | | $ | 17,016.1 | | | | | | | | | | (a) Other represents corporate assets which consist primarily of cash, property, plant, and equipment, and net deferred income tax assets. | | |
|